AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics08 October, 2020
bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfolio to African Union Member States.
The AMSP portal is an online marketplace that enables the supply of COVID-19-related critical diagnostics and medical equipment and consumables in Africa and the Caribbean Community (CARICOM). It was developed under the leadership of the African Union Special Envoy, Strive Masiyiwa and powered by Janngo, on behalf of the Africa Centres for Disease Control and Prevention (Africa CDC). The platform was developed in partnership with African Export-Import Bank (Afreximbank) and the United Nations Economic Commission for Africa (ECA).
This partnership with bioMérieux aims to respond to supply shortages experienced by African Union Member States by guaranteeing efficient, uninterrupted and rapid access to bioMérieux high-quality diagnostic solutions dedicated to the COVID-19 pandemic.
Under the partnership, a portfolio of high-quality diagnostic solutions (molecular testing and serology testing) for COVID-19 from bioMérieux will be available at very competitive prices to each of the 55 African Union Member States.
“To effectively respond to the COVID-19 pandemic, Africa needs continuous and predictable supply of diagnostics and medical consumables, and the AMSP was created to close the supply gap. Through AMSP we are building partnerships and exploring all markets, and we are delighted to have bioMérieux join this very important partnership,” said Dr John Nkengasong, Director of Africa CDC.
“We are very proud of this collaboration with AMSP, as it is part of our public health efforts which consist of allowing low and middle-income countries to have access to high quality diagnostics solutions in an ethical and equitable manner. It overall contributes to a better health for patients and communities in these countries at an affordable cost,” said Mr. Sindé Chekete, Vice-President, bioMérieux Africa.
“With the AMSP, Africa is leading the way to ensure all of our governments get access to test kits and other urgent medical supplies they need, at fair prices. We have been working relentlessly to expand choice & quality of supplies and that is why this partnership with bioMérieux is very important to us,” said African Union Special Envoy, Strive Masiyiwa.
“As a global leader pioneering diagnostics, bioMérieux’s commitment to fight infectious diseases for almost 60 years is highly commendable and we are very proud to partner with them through the AMSP. They are joining world class healthcare manufacturers in our fight against the pandemic in Africa,” concluded Fatoumata Bâ, Founder & Executive Chair of Janngo and Managing Partner of Janngo Capital.